1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
Kjellman, A. ; Akre, O. ; Gustafsson, O. ; Høyer-Hansen, G. ; Lilja, H. LU
; Norming, U.
; Piironen, T.
and Törnblom, M.
(2011)
In Journal of Internal Medicine
269(3).
p.299-305
- Contribution to journal › Article
- 2002
-
Mark
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases I in plasma by immunoassay
Holten-Andersen, MN ; Christensen, IJ ; Nielsen, HJ ; Lilja, Hans LU
; Murphy, G
; Jensen, V
; Brunner, N
and Piironen, T
(2002)
In Clinical Chemistry
48(8).
p.1305-1313
- Contribution to journal › Article
- 2000
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
Becker, Charlotte LU ; Piironen, T ; Pettersson, K ; Hugosson, J and Lilja, Hans LU
(2000)
In Urology
55(5).
p.694-699
- Contribution to journal › Article
-
Mark
Sensitive and specific immunodetection of human glandular kallikrein 2 in serum
Becker, Charlotte LU ; Piironen, T ; Kiviniemi, J ; Lilja, Hans LU
and Pettersson, K
(2000)
In Clinical Chemistry
46(2).
p.198-206
- Contribution to journal › Article
-
Mark
Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA
Nurmikko, P. ; Vaisanen, V. ; Piironen, T. ; Lindgren, S. and Lilja, H. LU
(2000)
In Clinical Chemistry
46(10).
p.1610-1618
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
Becker, Charlotte LU ; Piironen, T ; Pettersson, K ; Björk, Thomas LU ; Wojno, K J ; Oesterling, J E and Lilja, Hans LU
(2000)
In Journal of Urology
163(1).
p.311-316
- Contribution to journal › Article
- 1999
-
Mark
Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells
Väisänen, V. ; Lövgren, J. ; Hellman, J. ; Piironen, T. and Lilja, H. LU
(1999)
In Prostate Cancer and Prostatic Diseases
2.
p.91-97
- Contribution to journal › Article
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
Lilja, Hans LU
; Haese, A
; Björk, Thomas
LU
; Friedrich, M G
; Piironen, T
; Pettersson, K
; Huland, E
and Huland, H
(1999)
In Journal of Urology
162(6).
p.2029-2035
- Contribution to journal › Article
-
Mark
Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2
Leinonen, J. ; Leinimaa, M. ; Zhang, W. M. ; Piironen, T. ; Pettersson, K. ; Lilja, H. LU
; Dowell, B.
and Stenman, U. H.
(1999)
In Tumor Biology
20(SUPPL. 1).
p.35-37
- Contribution to journal › Article
-
Mark
Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen
- Contribution to journal › Article